Search: WFRF:(Amini Rose Marie)
> (2005-2009) >
Cyclin A is a proli...
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer
-
- Ahlin, Cecilia (author)
- Örebro universitet,Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi
-
- Zhou, Wenjing (author)
- Uppsala universitet,Endokrinkirurgi
-
Holmqvist, Marit (author)
-
show more...
-
- Holmberg, Lars (author)
- Uppsala universitet,Endokrinkirurgi
-
- Nilsson, Cecilia (author)
- Lund University,Lunds universitet,Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Centrum för klinisk forskning, Västerås,Enheten för pediatrisk hematologi,Forskargrupper vid Lunds universitet,Paediatric Hematologic Research Group,Lund University Research Groups
-
- Jirström, Karin (author)
- Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
-
- Blomqvist, Carl (author)
- Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi
-
- Amini, Rose-Marie (author)
- Karolinska Institutet,Uppsala universitet,Institutionen för genetik och patologi
-
- Fjällskog, Marie-Louise (author)
- Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi
-
show less...
-
(creator_code:org_t)
- 2009
- 2009
- English.
-
In: Cancer Epidemiology, Biomarkers and Prevention. - 1055-9965 .- 1538-7755. ; 18:9, s. 2501-2506
- Related links:
-
http://www.ncbi.nlm....
-
show more...
-
http://dx.doi.org/10...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
http://kipublication...
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- Background: Proliferative markers are not recommended as prognostic factors for clinical use in breast cancer due to lack of standardization in methodology. However, proliferation is driving several gene expression signatures emphasizing the need for a reliable proliferative marker IF or clinical use. Studies suggest that cyclin A is a prognostic marker with satisfying reproducibility. We investigated cyclin A as a prognostic marker in node-negative breast cancer using previously defined cutoff values. Patients and Methods: In a case-control study, we defined 190 women who died from breast cancer as cases and 190 women alive at the time for the corresponding case's death as controls. Inclusion criteria were tumor size <= 50 mm, no lymph node metastases and no adjuvant chemotherapy. Tumor tissues were immunostained for cyclin A using commercially available antibodies. Results: We found a statistically significant association between expression of cyclin A and breast cancer death in a univariate model: odds ratio for cyclin A(ave) 2.7 [95% confidence interval (CI), 1.7-4.3] and cyclin A(max) 3.4 (CI, 2.1-5.5). Corresponding odds ratio for Ki67 were Ki67(ave) 1.9 (CI, 1.2-3.1) and Ki67(max) 1.7 (CI, 1.1-2.7) and for grade 3.1 (CI, 1.8-5.1). Cyclin A was strongly correlated to Ki67 and grade why a model including all was not appropriate. Conclusions: Cyclin A is a prognostic factor for breast cancer death in node-negative patients using standardized methodology regarding scoring and cutoff values. Adding cyclin A as a proliferative marker to established clinicopathologic factors will improve the separation of low and high risk breast cancer.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- MEDICINE
- MEDICIN
- Medicin
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database